Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. - Wikidata - wikimedia - TriplyDB

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.

http://www.wikidata.org/entity/Q36752821

about

Molecular pathogenesis of pulmonary arterial hypertension Pulmonary hypertension: diagnostic and therapeutic challenges Pulmonary Arterial Hypertension and the Sex Hormone Paradox.N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol Sex differences in the pulmonary circulation: implications for pulmonary hypertension Kidney dysfunction in patients with pulmonary arterial hypertension Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension.Pulmonary venous occlusion and death in pulmonary arterial hypertension: survival analyses using radiographic surrogates.Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry Pulmonary hypertension in women.Connective tissue disease-associated pulmonary arterial hypertension.Lung transplantation for pulmonary hypertension.Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.Three-dimensional analysis of right ventricular shape and function in pulmonary hypertension.Diagnosis and risk stratification in patients with anti-RNP autoimmunity.Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension.Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.Pulmonary hypertension in parenchymal lung disease.Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population.Survival outcomes in severe congenital versus non-congenital pulmonary hypertension Latest advances in connective tissue disorders.Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction.Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.

P2860

Q24634317-E82B2042-F863-4A10-B9CE-24F3D0D5AA76 Q26796434-35D86B2D-5D20-414C-B5E8-E1D2518A5BDB Q30241478-2988D8EA-ED67-47DB-BA1C-A6FC1858B4E9 Q30463476-D1C2451E-8C92-4AB4-8CAE-AAB7E6D04B20 Q30490484-A0FC12C0-1BE0-4DC7-AAF5-33D1AE8967E4 Q33568826-FD127B68-0FB7-4CC2-BD77-7D162F25FEE5 Q33738621-1B6E6781-F7FB-4834-BF42-6DF52D5FA1C2 Q33788434-8A9837D9-29AD-4F3C-8E7C-4E944831E990 Q34040866-C01796A3-C3F7-4D12-B711-71F341229F28 Q34245617-7B8D5248-D671-4230-95C2-E1EF8BE2D902 Q34277188-4FC14336-A4A5-4343-B890-C267AB79BDDE Q34609902-2BD89E55-1118-4385-BA23-BB95A8A2D26C Q34795939-1D9B7309-354B-4880-9928-32E72DEFC6D5 Q35029607-B1EAC723-44FE-4515-B48A-444D69BC08E0 Q35412426-94FAAA1B-1191-464B-A3B4-AC607B6022CB Q35665758-EB8C24AE-4082-4DB6-AB05-53EF7496DED4 Q35867030-C34735DF-802A-4C59-8361-A23B23E6ECBD Q35929749-CA2F4FC1-8FC5-47A9-A325-BA90F7004265 Q35930490-7CE94049-607A-48E1-97B7-9E6DF92EFB75 Q36013002-A754319E-950A-46C6-A0B3-32C62C979823 Q36075442-7C3A82FA-E317-4081-BC9F-D842C2CD94BC Q36150934-8BD11230-C190-459D-936F-8F48ED977853 Q36246144-D102870A-CD16-4E34-A75D-75E51F546D49 Q36272405-A7E4FD80-2C6A-4713-9286-3F83A74168AC Q36272410-614D4CE4-478D-474B-8275-FE0ADA5F8CFE Q36307583-0CA53AB7-CC23-42ED-835F-2571C1060C61 Q36328903-8A872660-86EE-4F83-8990-62F3A134BC90 Q36490169-62CB40F0-B6EA-4FFE-8676-0F9C3DD809E1 Q36633190-6FAA0E31-9DF2-4D1A-AB06-D1C0E83829E9 Q36785465-D42CAFDF-0A25-419F-8E07-C5A5695E0139 Q36982766-C1389C09-C0F5-408E-94BE-E8E07EE4E42C Q37058776-BEE3EA5F-A686-4513-A961-CAE814C220D7 Q37069668-9479CC76-8013-40C9-8693-14CA4E08AD86 Q37106203-15D1F972-FD63-4A2F-B1E2-24AD000EA900 Q37185564-A93E90B0-1746-4EAC-9AC8-14758B5B21F9 Q37200751-08006267-BF11-48E7-B7B1-2DC14C45D0E6 Q37206944-75467288-9687-466D-9587-93EFD030A961 Q37274520-97514433-5237-4886-87A2-18EB21CC8C1D Q37300997-5018190A-4F9C-42C9-BDB7-5C4576E8265A Q37345940-CE7A6FA2-08E2-4FB0-A3C0-7E78E1F4010F

P2860

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.

http://www.wikidata.org/entity/Q36752821

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Characterization of connective ...... lerosis as a unique phenotype.

@en

type

label

Characterization of connective ...... lerosis as a unique phenotype.

@en

prefLabel

Characterization of connective ...... lerosis as a unique phenotype.

@en

P1433

Q36752821-2BCD480F-3CED-4ABA-84F0-FBB0EE308AE8

P1476

Q36752821-0079D774-234B-4290-A2C6-4AF8A455285F

P2093

Q36752821-0F7107D3-D344-4181-BCEC-AC3702B44BD4

Q36752821-5185464E-668D-4A2E-890D-8066089BE5E9

Q36752821-597A2904-4A27-4FC9-8EFA-12DFF38279F7

Q36752821-5C4F9422-EACF-4CFE-88AC-DEBD8884FFE3

Q36752821-A9B6E05B-49B8-45E7-9F3D-51A72A469AA1

Q36752821-B954ABCE-89EA-4615-900B-1D1A1FD7BD57

Q36752821-E12140E9-67C7-41F6-B44C-C066BAD1778D

Q36752821-E4541553-7CC2-4712-846B-BC7F7252A773

Q36752821-FCA76025-406F-4480-8BBB-74D51F0B80E8

P2860

Q36752821-0133A987-9A20-49E5-94D1-996676599590

Q36752821-06D349C1-7CEE-4AB0-86A7-7A1DDE5C186E

Q36752821-1959A57B-6DA7-4080-A8F9-070204601EED

Q36752821-1ABFF6D9-3534-47F8-9DE1-A1B83A93034A

Q36752821-31D5DB93-3201-48B2-B8CF-5B50E15FE395

Q36752821-35ECD4F9-3444-417C-851A-B0D2641C0FB8

Q36752821-41FCB8E8-2C34-4825-9178-10C6BA9CD297

Q36752821-4F2C0E96-45E9-43F4-9BB1-F78636075A20

Q36752821-71602DC5-698A-49A0-B848-500A6EB2A47F

Q36752821-7567BB53-88CA-47CD-A97A-C3DAE004D213

P304

Q36752821-5B95FDFC-4482-48B1-B17F-C29F2E3024B2

P31

Q36752821-E62FAFDE-760C-4E8B-885D-E986AD689648

P356

Q36752821-1F0D47F0-8DDC-411B-ABE3-4D28F9CD94BA

P407

Q36752821-C0E059CD-5E1A-4405-8650-8DFA9EC2F890

P433

Q36752821-4C9A140C-8354-41EE-8D5B-54915BB5C2D7

P478

Q36752821-B1E04E97-9A9A-49F0-9BCC-23A43F9F845E

P577

Q36752821-099CA74B-E138-4492-9397-A85F9B4DC227

P5875

Q36752821-F63EE391-43F5-4915-B236-86D0991DF6C4

P698

Q36752821-44D298C7-8976-4803-9B89-9FA9721FEA99

P921

Q36752821-936EE378-4C2D-4E5E-B315-ABFD05CEC78B

P932

Q36752821-3E3B891D-4C58-495B-B7E1-11B7EADAF394

P356

P1433

P1476

Characterization of connective ...... lerosis as a unique phenotype.

@en

P2093

Dave P Miller

http://www.w3.org/2001/XMLSchema#string

David B Badesch

http://www.w3.org/2001/XMLSchema#string

Juliana Liu

http://www.w3.org/2001/XMLSchema#string

Lori Parsons

http://www.w3.org/2001/XMLSchema#string

Lorinda Chung

http://www.w3.org/2001/XMLSchema#string

Mark R Nicolls

http://www.w3.org/2001/XMLSchema#string

Michael McGoon

http://www.w3.org/2001/XMLSchema#string

Paul M Hassoun

http://www.w3.org/2001/XMLSchema#string

Roham T Zamanian

http://www.w3.org/2001/XMLSchema#string

P2860

Updated clinical classification of pulmonary hypertension.

Pulmonary arterial hypertension in France: results from a national registry.

Raynaud's phenomenon.

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

Changes in causes of death in systemic sclerosis, 1972-2002

Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.

Pulmonary arterial hypertension associated to connective tissue diseases.

Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension.

P304

1383-1394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.10-0260

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44635556

http://www.w3.org/2001/XMLSchema#string

P698

20507945

http://www.w3.org/2001/XMLSchema#string

P921

connective tissue

P932

3621419

http://www.w3.org/2001/XMLSchema#string